Newsroom

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the Jefferies Global Healthcare Conference in London on Tuesday, November 17, 2026, with a fireside chat at 9:30 a.m. GMT. The live webcast of this event can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com. An archived webcast will be available on the Company’s website. About BeOne Me...

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, today reported financial results for the third quarter ended September 26, 2026. The Company reported $3.5 billion in sales with total growth of 4.0%, and 3.1% internally in local currencies. GAAP earnings per share grew 26.2% versus the prior year. Non-GAAP earnings per share grew 13.0%, or 19.1% when excluding current-quarte...

WIXOM, Mich.--(BUSINESS WIRE)--Rockwell Medical is acquiring Vantive’s HD concentrates, HD machines, water treatment systems, and related consumables and technical services business...

SANTA CLARA, Calif.--(BUSINESS WIRE)--xMEMS Labs showcases solid-state cooling and audio innovations at CES 2027, helping drive the next generation of Edge AI devices. Reserve a meeting....

TAIPEI, Taiwan--(BUSINESS WIRE)--PharmaEssentia’s blood cancer treatment, ropeginterferon alfa-2b (Ropeg), has secured approvals for essential thrombocythemia (ET) in Taiwan, Japan, the United States, and China, widening treatment options for patients with the chronic disease. In Europe, however, the ET indication remains unapproved, underscoring the gap between clinical advances and patient access across global markets. Developed and manufactured by the Taiwan-based biopharmaceutical company P...

CHICAGO--(BUSINESS WIRE)--Bringg introduces Performance AI, intelligence that works at the decision point, not the dashboard, for smarter last-mile decisions...

WALTHAM, Mass.--(BUSINESS WIRE)--Netcracker is a leader in IDC MarketScape: Worldwide Telecom Autonomous Network Operations Solutions 2026 Vendor Assessment....

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today reported financial results for the third quarter ended October 4, 2026. The Company reported GAAP earnings per share from continuing operations of $0.56, as compared to $0.41 in the same period a year ago. Revenue for the quarter was $729 million, as compared to $699 million in the same period a year ago. GAAP operating income from continuing operations for the quarter was $95 million, as compared to $82 million for the same per...

CHICAGO--(BUSINESS WIRE)--ADM (NYSE: ADM) today reported financial results for the quarter ended September 30, 2026 and updated its full-year 2026 outlook, including an increase to adjusted EPS guidance. 3Q26 Key Takeaways: Net earnings of $821 million, with adjusted net earnings1 of $858 million EPS2 of $1.70, with adjusted EPS1,2 of $1.77 2026 Outlook3: ADM now expects 2026 adjusted EPS1,2 of approximately $5.50 to $5.80, up from the prior adjusted EPS guidance range of $5.15 to $5.60 The upd...